Type 1 diabetes usually begins in children and young adults, but it can happen at any age. For those who are undiagnosed, the ...

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...

The world's first artificial pancreas rollout improved blood sugar control, reduced diabetes burden, and expanded equitable ...

It has been dubbed the biggest diabetes breakthrough for a century.

A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is effective, laying the groundwork for a UK-wide childhood screening program.

Almost 6 million people in the UK are living with diabetes, with many unaware they have the condition ...

A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.

Teplizumab is used to delay the onset of stage 3 type 1 diabetes in children aged 8 years and older, and adults, with stage 2 ...

Sanofi Diabetes, a division of Sanofi-Aventis, has launched a new mobile game for iOS and Android phones in the United Kingdom. The game, called Mission T1D, is meant to be educational, to teach ...